-
10:00
[01] A hybrid nonparametric framework for outlier detection in functional time series
-
David Solano
(Research Group on Statistics, Econometrics and Health (GRECS). University of Girona)
-
10:05
[02] Adjust for Positional Uncertainty in Spatial Modeling
-
Manuel Moreno
(universitat de girona)
-
10:10
[03] An Evaluation Metric for Detection-Based Object Counting
-
Agnieszka Kubik-Komar
(University of Life Sciences in Lublin)
-
10:15
[04] Bridging Data Gaps for Better Groundwater Protection: Advanced Imputation Meets Spatial Modelling
-
Urszula Bronowicka-Mielniczuk
(University of Life Sciences in Lublin/Department of Applied Mathematics and Computer Science)
-
10:20
[05] Comparing existing methods to address the multiplicity of analysis strategies: A case study in pharmacoepidemiology
-
Moritz Pamminger
(Medical University of Vienna, Center for Medical Data Science, Institute of Clinical Biometrics)
-
10:25
[06] Comparison of statistical methods for analysis of treatment effects on repeated patient reported outcomes in randomized clinical trials
-
Agnieszka Król
(AstraZeneca)
-
10:30
[07] Designing an integrated longitudinal data platform for exercise-based management of patients with multiple chronic conditions
-
Nasrin Salimian
(Pardis Specialized Wellness Institute)
-
10:35
[08] Developing Statistical Power Estimation Models for Spatial Transcriptomics
-
Miglė Gervytė
(Institute of Data Science and Digital Technologies, Faculty of Mathematics and Informatics, Vilnius University)
-
10:40
[09] Early molecular deviations as predictors of non-communicable diseases
-
Zita Zarándy
(Center for Molecular Fingerprinting, Semmelweis University)
-
10:45
[10] Ensuring Quality in Preclinical Research: The Importance of Being Human
-
Tina Lang
(Bayer AG)
-
10:50
[11] Exact conditional likelihood inference in meta-analysis for estimating risk ratio
-
Hisashi Noma
(The Institute of Statistical Mathematics)
-
10:55
[12] Fraction-of-Time and robust periodic ARMA for improved analysis of digital health monitoring data
-
Stanislaw Leskow
(Warsaw School of Economics (SGH))
-
11:00
[13] Impact of Tumor-Assessment Schedules on the Projected Timing of PFS Analyses in Oncology Trials
-
Laura Kohlhas
(Cogitars)
-
11:05
[14] Influence of documentation quality on the reproducibility of animal research
-
Tomke Eiben
(University of Applied Sciences and Arts, Hannover, Germany)
-
11:10
[15] Joint modelling of general and mental health using copula models: a simulation-based evaluation for COVID-19 health research.
-
Katarzyna Jagoda
(University of Plymouth)
-
11:15
[16] MISSING OBSERVATIONS IN RESEARCH ON NITROGEN DIOXIDE CONTENT IN THE AIR
-
Dorota Domagała
(University of Life Sciences in Lublin)
-
11:20
[17] Machine Learning Imputation of Air Pollutant Concentrations Using XGBoost
-
Dorota Domagała
(University of Life Science)
-
11:25
[18] Modelling of alder pollen concentration
-
Małgorzata Graczyk
(Poznań University of Life Sciences)
-
11:30
[19] Optimal Grouping for Weibull Modeling of Fertilizer Granule Strength
-
Paweł Kurasiński
(University of Life Sciences in Lublin City: Lublin)
-
11:35
[20] Optimal cutoff selection for U-shaped prognostic variable in survival data with competing risk
-
Sook-young Woo
(Samsung Medical Center)
-
11:45
[22] Polygenic Risk Modeling in Periodontitis: Insights from a Case-Control Study of 4,243 European Cases and Current Limitations
-
Gesa Richter
(Department of Periodontology, Oral Medicine and Oral Surgery, Charité – Universitätsmedizin Berlin, Berlin, Germany)
-
11:50
[23] Predictive multivariate models and ordination analyses reveal drivers of degradation and plant invasion in the Biała and Czarna Łada river valleys
-
Monika Różańska-Boczula
(University of Life Sciences in Lublin)
-
11:55
[24] Preprocessing of MALDI-TOF mass spectrometry data for prediction of antimicrobial resistance via machine learning
-
Dominic Enders
(Institute of Biostatistics and Clinical Research, University of Münster)
-
12:00
[25] Realise D: compRehensive mEthodological and operational Approach to cLinical trIalS in ultra-rarE Diseases
-
Christoph Gerlinger
(Bayer AG, Clinical Statistics and Analytics, Berlin and Department of Gynecology, Obstetrics and Reproductive Medicine, University Medical School of Saarland)
-
12:05
[26] Reanalysis and sensitivity analysis of overall survival and progression-free survival of pivotal randomized controlled trials in oncology
-
Giulia Varvarà
(University of Rennes)
-
12:10
[27] Social capital, depression, place of residence and periods before and after the COVID-19 pandemic: a logistic regression analysis
-
Karolina Majdak
(Jagiellonian University Medical College, Chair of Epidemiology and Preventive Medicine, Department of Medical Sociology)
-
12:15
[28] Survival of breast cancer patients treated at Tikur Anbessa specialized and Teaching Hospital, Addis Ababa Ethiopia.
-
Fatuma Hassen
(Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.)
-
12:20
[29] The assessment of construct validity using Item Response Theory models: An example based on the Online Social Capital Index (OSCI) for middle-aged and older people
-
Michalina Gajdzica
(Jagiellonian University - Medical College, Chair of Epidemiology and Preventive Medicine)
-
12:25
[30] Therapeutic Intervention Effects in Children with Autism Spectrum Disorder: A Pre–Post Statistical Analysis Using Respondent-Driven Sampling (RDS)
-
Syntia Souza
(UFRPE)
-
12:30
[31] Trends and predictors of in-hospital survival among asphyxiated neonates admitted at Kilimanjaro Christian Medical Center, Northern Tanzania: Retrospective Cohort Study
-
Jovin Tibenderana
(St Francis University College of Health And Allied Sciences)
-
12:35
[32] Twenty-Five Years of Oncology Clinical Trials: Trends from ClinicalTrials.gov (2000–2025)
-
Beth McDougall
(Department of Statistics, Phastar)
-
12:40
[33] Win statistics in design and analysis of non-inferiority trials
-
Johanna Ledoux
(University of Zurich, Department of Biostatistics)